孔源性视网膜脱离(RRD)是一种临床常见的致盲性眼科疾病，在临床治疗中一直备受关注。折叠顶压球囊作为一种新的从外路治疗RRD的治疗手段，相较于传统治疗方法包括巩膜扣带术、平坦部玻璃体切除术和充气性视网膜固定术，具有“五不”优势——不球后麻醉、不牵拉肌肉、不巩膜放液、不术中定位和不裂孔冷冻。其有效降低了RRD患者的术后并发症，缩短了手术时间。文章旨在介绍折叠顶压球囊的发展历程与治疗原理，着重阐述其对于RRD的治疗优势、适应证选择以及有效性与安全性。折叠顶压球囊有望通过技术创新和应用领域拓展，在多种视网膜疾病的治疗中发挥更加重要的作用。

Rhegmatogenous retinal detachment(RRD)is a common blinding ophthalmic disease that has always received significant attention in clinical treatment. The foldable capsular buckle(FCB), as a new method for extraocular treatment of RRD, offers“Five Noes” advantages over traditional treatments such as scleral buckling(SB), pars plana vitrectomy(PPV), and pneumatic retinopexy(PR), including no retrobulbar anesthesia, no muscle traction, no scleral fluid release, no intraoperative positioning, and no cryotherapy. This effectively reduces postoperative complications in RRD patients and shortens the operation time. This review aims to investigate the development process and treatment principle of FCB, and focus on its therapeutic advantages, indication selection, efficacy and safety for RRD. It is expected to play a more important role in the treatment of a variety of retinal diseases through technological innovation and application field expansion.